From the source
Microsoft Research's podcast The Shape of Things to Come brought together three experts to discuss what AI can do today in medicine and biology and what must happen first.
- Host Doug Burger was joined by
Microsoft chief scientific officer Eric Horvitz, Scripps Research executive vice president Eric Topol, and Microsoft principal research manager Ava Amini, who co-leads Project Ex Vivo with the Broad Institute.
- Horvitz said healthcare and the biosciences are fortunate because decades of digitalized content, from protein structures to electronic health records, make them ready for AI inference and innovation.
- He pointed to discriminative and generative models over the last five to eight years, calling the AlphaFold breakthrough the tip of the iceberg, and said AI can assist experimental design, data interpretation and hypothesis generation alongside human scientists.
- In healthcare, Horvitz said there is an extraordinary opportunity to address long-term challenges in patient safety, timely diagnoses and accessibility.
- The group also examined AI-assisted medical diagnosis, medical imaging, whole-patient models, virtual cells and biological foundation models, and asked why promising research is slow to reach patients.
- They said better biological data and real-world validation remain essential.






